Subscribe: WSJ.com: Health
http://online.wsj.com/xml/rss/3_7089.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
cancer  care  companies  company  drug  epipen  fda  health care  health  medical  mylan  new  price increases  treatment  zika 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: WSJ.com: Health

WSJ.com: Health



Health



Last Build Date: Sat, 01 Oct 2016 16:56:32 EDT

Copyright: copyright © 2016 Dow Jones & Company, Inc.
 



Depomed Gets Favorable Nucynta Patent Decision

Fri, 30 Sep 2016 17:40:34 EDT

Depomed Inc. said it received a favorable court decision on its patents for its Nucynta painkiller products and expected the ruling would result in market exclusivity through 2025.



GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe

Fri, 30 Sep 2016 17:05:27 EDT

GlaxoSmithKline PLC agreed to pay $20 million to settle charges that the drugmaker’s Chinese subsidiaries engaged in bribery schemes to increase sales in the Asian country, the Securities and Exchange Commission said Friday.



Honest Co. to Drop Disputed Ingredient in Cleaning Products

Sat, 01 Oct 2016 16:55:58 EDT

Jessica Alba’s Honest Co. is reformulating its laundry detergent and other cleaners, removing an ingredient that has created controversy for the company over its product claims.



For Small-Town Cops, Opioid Scourge Hits Close to Home

Thu, 29 Sep 2016 09:59:16 EDT

A flood of fentanyl and heroin is straining local budgets, putting police at risk as drug networks spread.



FDA Approves Medtronic's New Automated Insulin Pump

Wed, 28 Sep 2016 20:30:17 EDT

The U.S. Food and Drug Administration said it has approved an insulin pump by medical device company Medtronic that automatically manages glucose levels within a target range.



Intra-Cellular Therapies Shares Plunge After Disappointing Drug Trial Results

Thu, 29 Sep 2016 10:46:28 EDT

Intra-Cellular Therapies said its lead drug candidate had a similar rate of effectiveness to placebo in a Phase 3 schizophrenia trial.



Varying Sick-Leave Laws Vex Some Employers

Tue, 27 Sep 2016 14:03:17 EDT

Across the country, new laws are requiring paid sick leave for more workers, but employers are having a hard time keeping up with regulations that differ in each jurisdiction.



Making Sense of the Salt Shaker

Wed, 28 Sep 2016 10:04:33 EDT

Chefs and home cooks are shaking their heads over federal recommendations to reduce sodium intake to the equivalent of one teaspoon of table salt a day.



Mylan's EpiPen Pretax Profits 60% Higher Than Number Told to Congress

Tue, 27 Sep 2016 00:50:00 EDT

Mylan says that the $100 profit per two-pack of its EpiPen injectors presented by CEO Heather Bresch to Congress last week is actually 60% higher.



Medical Record Mix-Ups a Common Problem

Sun, 25 Sep 2016 22:49:31 EDT

Patient-identification mix-ups are common and can have deadly consequences, according to a report from the ECRI Institute, a nonprofit research group that studies patient safety.



The Revolution in EMS Care

Mon, 26 Sep 2016 15:11:53 EDT

Thanks to new technology, new life-saving techniques and new missions, ambulance crews are far from the ‘horizontal taxicabs’ they once were.



Physicians and Physicists Join to Fight Pancreatic Cancer

Sun, 25 Sep 2016 22:30:57 EDT

By bringing together experts from different fields, scientists seek answers to complex medical problems.



Why Hospitals Want More Personal Data About Patients

Thu, 29 Sep 2016 10:11:46 EDT

In an effort to predict health problems, providers look at a much broader range of personal information.



How an iPhone Flashlight Led to a Low-Cost Surgical Tool

Mon, 26 Sep 2016 00:52:59 EDT

A cheap device could make surgery more available in poorer countries.



Sick Children Face Danger From Medication Errors

Sun, 25 Sep 2016 22:37:37 EDT

Younger patients are vulnerable to mistakes made in how much medicine to give and when to give it.



The Key to Health-Care Innovation in Developing Nations

Mon, 26 Sep 2016 10:19:10 EDT

Success depends on understanding the conditions and resources of the local community.



New Devices Let Doctors Make House Calls---Remotely

Sun, 25 Sep 2016 22:36:43 EDT

Diagnostic gadgets let patients do tests at home and send the information to a doctor.



Technology and Health Care: The View From HHS

Sun, 25 Sep 2016 22:33:59 EDT

Chief Technology Officer Susannah Fox discusses the need to create a culture of innovation



Nuclear-Imaging Tests Show Promise in Finding Cancer

Mon, 26 Sep 2016 09:36:49 EDT

New tests could lead to more accurate prognosis and treatment of prostate cancer, among others.



How 'Wellness Coaching' Can Break Unhealthy Habits

Wed, 28 Sep 2016 10:37:50 EDT

Some research suggests wellness coaching can help people change behaviors—at least in the short term.



Merck's Keytruda Finds Fast Entry Into China Via Medical-Tourism Push

Sat, 24 Sep 2016 03:04:33 EDT

Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism.



Breakthrough Gene Tool Attracts Investors Amid Patent Dispute

Thu, 22 Sep 2016 22:13:49 EDT

Companies are seeking to capitalize on a hot new gene technology, though a high-stakes patent dispute has yet to be settled. The gene-editing tool, known as Crispr-Cas9, serves as a kind of multipurpose molecular scissors that can cut DNA.



Mylan CEO Faces Tough Questioning in EpiPen Hearing

Thu, 22 Sep 2016 09:16:12 EDT

Mylan NV CEO Heather Bresch faced tough questioning Wednesday from Republicans and Democrats in Congress probing price increases for the EpiPen allergy treatment.



Zuckerberg Family Fund to Invest $3 Billion in Research Technology

Thu, 22 Sep 2016 19:54:26 EDT

Facebook Chief Executive Mark Zuckerberg and his wife Priscilla Chan on Wednesday committed to invest more than $3 billion over the next decade to build technology that can speed up research on disease.



Anthem, Cigna Accuse Each Other of Merger Breach

Thu, 22 Sep 2016 09:53:30 EDT

Anthem and Cigna have accused one another of violating the terms of their merger agreement, according to a legal filing by the Justice Department.



Reckitt Benckiser Apologizes for Disinfectant Deaths

Thu, 22 Sep 2016 04:41:20 EDT

More than 100 people, mainly pregnant women and infants, are known to have been killed in South Korea by Reckitt’s humidifier disinfectant.



Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal

Tue, 20 Sep 2016 21:40:58 EDT

Allergan agreed to acquire Tobira Therapeutics, which focuses on therapies for liver diseases, in a deal worth as much as $1.7 billion, or 19 times Tobira’s previous market value.



GlaxoSmithKline Names Emma Walmsley as Next CEO

Tue, 20 Sep 2016 21:55:04 EDT

GlaxoSmithKline said its head of consumer health care, Emma Walmsley, will succeed Andrew Witty as chief executive next year.



U.S. Court Throws Out Judgment Against Chinese Vitamin C Makers

Tue, 20 Sep 2016 22:15:12 EDT

A federal appeals court threw out a $147 million civil price fixing judgment against Chinese makers of vitamin C, ruling the companies weren’t liable in U.S. courts because they were acting under the direction of Chinese authorities.



Bullish Bayer Boss Defends Monsanto Deal

Tue, 20 Sep 2016 16:44:20 EDT

Germany’s Bayer is targeting increased sales and earnings growth over the next few years at its drug and crop-science businesses, just days after announcing a planned $66 billion takeover of U.S. seed supplier Monsanto.



Florida Declares Miami's Wynwood Neighborhood Zika Free

Mon, 19 Sep 2016 21:34:59 EDT

Florida authorities said they no longer believe mosquitoes are spreading the Zika virus in Miami’s Wynwood neighborhood, despite the expanded potential transmission zone in nearby Miami Beach.



Sanofi Files Suit Against Merck

Mon, 19 Sep 2016 11:19:19 EDT

Sanofi said it filed a lawsuit against Merck & Co. for alleged patent infringements to prevent the U.S. drugmaker from launching a rival version of the French pharmaceutical giant’s best-selling diabetes treatment Lantus.



Community Health Systems Exploring Alternatives

Mon, 19 Sep 2016 10:08:39 EDT

Community Health Systems, one of the largest U.S. hospital companies, is exploring a deal after struggling to digest its acquisition of Health Management Associates.



FDA Approves Sarepta's Dystrophy Drug

Mon, 19 Sep 2016 20:27:49 EDT

The FDA gave accelerated approval to the first drug for the crippling disease Duchenne muscular dystrophy, from Sarepta, after sharp disagreements within the agency.



WebMD CEO Departs By 'Mutual Agreement'

Mon, 19 Sep 2016 21:49:27 EDT

David Schlanger is out as chief executive at WebMD Health Corp., the company said Monday, after a three-year stint leading the health-care advice website.



Who's Ready for Information Storage Under Their Skin?

Fri, 23 Sep 2016 14:02:56 EDT

Tiny implants can replace keys, store business cards and medical data—and eventually a lot more.



VCs See Potential in the Microbiome

Sun, 18 Sep 2016 22:44:57 EDT

Venture capital floods into companies trying to use microbiome science to achieve breakthroughs in medicine, agriculture and other fields.



New U.S. Rule to Expand Requirements for Publication of Clinical Trials

Fri, 16 Sep 2016 20:15:27 EDT

Federal health officials will soon be requiring scientists and companies to make public more details of a broader range of medical research studies, even if the results are disappointing.



Depomed to Hold Nov. 15 Shareholder Meeting

Mon, 19 Sep 2016 13:33:53 EDT

Depomed Inc. said it would hold a special shareholder meeting on Nov. 15 as the drug company battles Starboard Value LP’s efforts to replace its board.



Bayer CEO Sets Course With Monsanto Deal

Fri, 16 Sep 2016 11:36:13 EDT

Bayer CEO Werner Baumann just pulled off the deal of his career. Now, less than five months in as CEO, his career could hinge on his ability to close the $57 billion acquisition of Monsanto agreed to Wednesday and to make the combination pay for investors.



Cup Noodles Dials Down the Salt

Fri, 16 Sep 2016 10:24:44 EDT

Cup Noodles said it has drastically reduced the sodium content of its instant ramen and removed artificial flavors, adding ingredients like paprika and lime.



FDA Cracks Down on Online Sales by E-Cigarette Industry

Fri, 16 Sep 2016 10:23:58 EDT

A month after assuming regulatory oversight over e-cigarettes, the U.S. Food and Drug Administration has cracked down on online sales by the industry, issuing 24 letters to websites for illegal sales to minors.



Novavax Shares Plummet After Unfavorable Data

Fri, 16 Sep 2016 10:21:35 EDT

Novavax shares fell 84% in after-hours trading after the vaccine company reported unfavorable results from two clinical trials.



Use of Illicit Drugs Is on the Rise Among Workers

Thu, 15 Sep 2016 14:29:00 EDT

The share of U.S. workers testing positive for illicit drug use reached its highest level in a decade, according to data from millions of workplace drug tests administered by Quest Diagnostics, one of the nation’s largest medical-screening laboratories.



Allergan to Buy Vitae Pharmaceuticals for $639 Million

Wed, 14 Sep 2016 22:46:26 EDT

Allergan agreed to acquire clinical-stage biotechnology company Vitae Pharmaceuticals for $639 million, more than double its market value, in a move aimed at strengthening the drugmaker’s skin-care pipeline.



EpiPen Maker Executive to Testify at House Hearing

Thu, 15 Sep 2016 12:19:07 EDT

Lawmakers have summoned the top executive from EpiPen maker Mylan to Washington for a hearing next week to explain substantial price increases for the emergency allergy treatment that have generated widespread consumer outrage.



Average Cost of Employer Health Coverage Tops $18,000 for Family

Wed, 14 Sep 2016 22:18:55 EDT

The average cost of employer health coverage pushed above $18,000 for a family this year, though the pace of growth was slowed by the shift into high-deductible plans.



Beverage Industry Sues to Block Philadelphia's Sweetened-Drink Tax

Wed, 14 Sep 2016 19:50:29 EDT

Beverage companies and retailers filed a civil complaint, saying state law prevents cities from imposing duplicate taxes. The tax is scheduled to go into effect in January.



Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix

Thu, 15 Sep 2016 13:43:23 EDT

Pfizer Inc. said two federal advisory panels have recommended removing the most serious warnings on its Chantix smoking cessation pill, clearing a major hurdle in the pharmaceutical giant’s push to lessen concerns about using the medicine.



EpiPen Maker Mylan Dispenses Outsize Executive Pay

Wed, 14 Sep 2016 10:34:33 EDT

Mylan, assailed for hefty price increases on its lifesaving EpiPen, had the second-highest executive pay among all U.S. drug and biotech firms over the past five years, paying its top five managers a total of nearly $300 million.



World Doping Agency Says Olympic Database Hacked

Wed, 14 Sep 2016 10:41:59 EDT

The World Anti-Doping Agency said Russian hackers had stolen confidential medical records of athletes who participated in last month’s Olympic Games in Rio de Janeiro.



Costly Drugs for Prisoners Weigh on Public Budgets

Tue, 13 Sep 2016 12:38:37 EDT

Thousands of convicted criminals have hepatitis C, an infectious disease that is one of the country’s biggest killers, but only the sickest qualify for medicines because they are so expensive.



Obama Pledges Redoubled Efforts to Make Health Law Successful

Tue, 13 Sep 2016 10:07:09 EDT

President Barack Obama made a personal bid to shore up his signature health law as it heads into its final test of his administration.



Scientists Honored for Hep C Research

Tue, 13 Sep 2016 00:04:14 EDT

Three scientists whose work helped transform hepatitis C treatment, including the lead inventor of a multibillion-dollar drug from Gilead Sciences, are among the winners of the 2016 Lasker Awards, one of the highest honors in medical research.



Google Parent and Sanofi Name Diabetes Joint Venture Onduo

Mon, 12 Sep 2016 21:56:04 EDT

French pharmaceutical group Sanofi is joining with Verily Life Sciences, a unit of Google parent Alphabet, to create a joint venture called Onduo to research diabetes treatments.



3-D Printing Startup Seeks Niche in Low-Cost Prosthetic Legs

Mon, 12 Sep 2016 22:10:38 EDT

Japanese startup SHC Design plans as soon as next April to start selling what it believes is the first self-contained 3-D printing system for producing prosthetic limbs.



Starboard Value Takes 4.6% Stake in Perrigo

Mon, 12 Sep 2016 09:57:54 EDT

Starboard Value has built a 4.6% stake in Perrigo, worth nearly $600 million, and is urging the drug company to refocus on its core business.



Apple Shifts Focus to Fitness With Latest Watch

Mon, 12 Sep 2016 00:47:35 EDT

Apple designed its new Series 2 watch to be water resistant to a depth of 50 meters. The tech giant also touted a partnership with Nike to market sports-themed watches.



Zika-Funding Deal Nears With Talk of Dropping Planned Parenthood Clause

Fri, 09 Sep 2016 20:44:01 EDT

Lawmakers are edging closer to breaking an impasse over funds to combat the Zika virus, with many expecting Republicans to drop a contentious provision blocking funds to clinics in Puerto Rico that work with Planned Parenthood.



Health Law Faces Critical Year

Wed, 07 Sep 2016 21:55:07 EDT

Significant spikes in premiums, insurer dropouts and persistently low enrollment numbers are combining to make this fall’s sign-up period a crucial one for the Obama administration’s signature health law.



Zika Fears Expected to Boost Demand for Condoms

Wed, 07 Sep 2016 13:16:42 EDT

Malaysia-based Karex, the world’s largest condom maker by volume, considers spreading concern about the Zika virus a long-term boost for demand.



FDA to Review Merck Drug as First-Line Treatment for Lung Cancer

Wed, 07 Sep 2016 09:45:17 EDT

The FDA will review Merck’s immunotherapy cancer drug Keytruda as a first-line treatment for patients with the most common form of lung cancer.



St. Jude Medical Sues Muddy Waters

Wed, 07 Sep 2016 10:29:28 EDT

St. Jude Medical filed a lawsuit against Muddy Waters, accusing the research firm of intentionally making false claims about its heart devices to profit from a stock decline.



Alcohol Companies Push Back Against U.K. Health Warnings

Wed, 07 Sep 2016 14:39:51 EDT

The world’s biggest alcohol companies have banded together to fight British government warnings about the dangers of drinking, funding a group called the Alcohol Information Partnership.



Arizona's Pinal County Gains Health-Law Exchange Insurer

Thu, 08 Sep 2016 00:08:22 EDT

Blue Cross Blue Shield of Arizona will offer plans on the Affordable Care Act exchange in Arizona’s Pinal County next year, resolving a situation that drew a national spotlight because it represented a major challenge to the mechanics of the health law.



Percentage of Uninsured at Historic Low

Wed, 07 Sep 2016 12:53:30 EDT

The number of uninsured people in the U.S. remained at a historic low in early 2016, according to a federal survey that found 8.6% of respondents without health coverage.



Merck Discontinues Development of Osteoporosis Drug

Fri, 02 Sep 2016 10:34:52 EDT

Merck said it would discontinue developing the osteoporosis drug odanacatib and not seek regulatory approval for the treatment because it carries a higher risk of stroke.



EpiPen Maker Mylan Tied Pay to Aggressive Profit Targets

Thu, 01 Sep 2016 15:54:31 EDT

The drugmaker at the center of a firestorm over hefty price increases on the lifesaving EpiPen put a special incentive plan in place more than two years ago that rewards executives only if they hit aggressive profit targets.



Takeda Gets Financial Help From U.S. in Developing Zika Vaccine

Thu, 01 Sep 2016 21:41:22 EDT

The U.S. government has pledged $19.8 million to help Takeda Pharmaceutical Co. pay for initial development of a Zika vaccine under a contract that could go up to $312 million.



Biogen's Alzheimer's Therapy Granted FDA Fast-Track Status

Fri, 02 Sep 2016 10:36:34 EDT

Biogen said its investigational therapy for the early stage of Alzheimer’s disease was granted fast-track designation by the U.S. Food and Drug Adminstration.



Insurers Move to Limit Options in Health-Care Exchange Plans

Wed, 31 Aug 2016 23:44:38 EDT

Under intense pressure to curb costs that have led to losses on the Affordable Care Act exchanges, insurers are accelerating their move toward plans that offer limited choices of doctors and hospitals.



FDA Heightens Warning About Drug Combinations

Wed, 31 Aug 2016 22:46:51 EDT

The Food and Drug Administration on Wednesday issued its most serious safety warning about combining narcotic painkillers with certain sedative drugs.



Theranos Walks Away From Zika Test

Tue, 30 Aug 2016 22:48:02 EDT

The blood-testing company withdrew its request for regulatory clearance after the FDA found that a study didn’t include proper patient safeguards.



Walgreens Forms Alliance With Prime Therapeutics

Mon, 29 Aug 2016 17:30:20 EDT

Walgreens Boots Alliance has struck a partnership with Prime Therapeutics to help it capture a greater share of the prescription-drug market and better compete with CVS Health.



Martin Shkreli Sells Remaining Stake in KaloBios

Mon, 29 Aug 2016 17:33:57 EDT

Martin Shkreli has sold his remaining stake in KaloBios, severing his ties with the company he once led as the small drugmaker seeks to distance itself from its former chief executive.



Health Insurers' Pullback Threatens to Create Monopoly Zones

Mon, 29 Aug 2016 10:57:00 EDT

Nearly a third of U.S. counties look likely to have just a single insurer offering health plans on the ACA’s exchanges next year, according to a new analysis, an industry pullback that adds to the challenges facing the law.



Glaxo Bets It Can Shake Up HIV Treatment

Mon, 29 Aug 2016 06:00:52 EDT

GlaxoSmithKline is pinning the future of its HIV business on an audacious bet: upending the decades-old triple-drug treatment strategy that has turned a fatal illness into a chronic condition.



Senator to Propose Cancer Registry for Firefighters

Sun, 28 Aug 2016 22:18:47 EDT

Sen. Charles Schumer said he would propose legislation creating a national registry tracking cancer rates among U.S. firefighters, something he said would help researchers root out toxic building materials.



Singapore Reports 41 Local Zika Cases

Mon, 29 Aug 2016 09:01:04 EDT

The Ministry of Health said the patients weren’t known to have traveled to Zika-affected areas recently and thus are likely to have been infected in Singapore.



FDA Wants Zika Testing for All Donated Blood

Sat, 27 Aug 2016 20:43:42 EDT

The Food and Drug Administration is calling for Zika testing of all donated blood and blood products nationwide as a preventive measure to help stem the spread of the virus.



St. Jude Denies Claims in Muddy Waters Report

Fri, 26 Aug 2016 17:26:35 EDT

St. Jude Medical on Friday denied allegations made by a research firm that its pacemakers and other heart devices were vulnerable to hacking and other cybersecurity threats.



Avian Flu Found in Wild Duck in Alaska

Fri, 26 Aug 2016 17:25:54 EDT

A highly lethal form of avian flu was detected in a wild mallard duck in Alaska, reigniting fears of a return of the virus that hasn't been spotted in the U.S. for more than a year.



Mylan's EpiPen Price Increases Highlight Its Grip on the Market

Fri, 26 Aug 2016 08:37:56 EDT

The ability of Mylan to raise EpiPen’s list price by nearly 550% over the past eight years underscores the pricing power drug companies enjoy for iconic brands facing little competition.



Burden of Health-Care Costs Moves to the Middle Class

Thu, 08 Sep 2016 15:44:20 EDT

Rising out-of-pocket health care costs, combined with slow economic growth and years of tepid wage growth, pose risks for an economy in which consumer spending accounts for more than two-thirds of overall output.



Mylan Faces Scrutiny Over EpiPen Price Increases

Wed, 24 Aug 2016 22:58:04 EDT

Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.



Pfizer Buys Part of AstraZeneca's Antibiotics Business

Wed, 24 Aug 2016 17:10:07 EDT

Pfizer said the deal would boost its stable of older products, some of which have lost patent protection.



Jeni's Splendid Ice Creams Gets FDA Warning After Plant Inspections

Wed, 24 Aug 2016 17:23:50 EDT

The Food and Drug Administration said it found a dangerous form of listeria in the company’s Columbus, Ohio, manufacturing plant that supplies the base for Jeni’s ice creams and frozen yogurts.



FDA Rejects Amgen Hormonal-Imbalance Treatment

Thu, 25 Aug 2016 11:22:03 EDT

Amgen Inc. said Wednesday that government regulators have rejected its new drug application for its therapy for a hormonal imbalance common in patients on dialysis.



Pfizer Adds Key Cancer Drug With $14 Billion Medivation Deal

Mon, 22 Aug 2016 20:56:44 EDT

Pfizer agreed to buy biotech Medivation for about $14 billion, in a move that adds one of the crown jewels of the multibillion-dollar market for cancer drugs to Pfizer’s portfolio.



Apple Purchases Medical Startup Gliimpse

Mon, 22 Aug 2016 14:43:44 EDT

Apple has quietly purchased Gliimpse, a three-year-old startup that aims to help patients make sense of their medical records.



Valeant Hiring Paul Herendeen as New CFO

Mon, 22 Aug 2016 09:48:23 EDT

Valeant Pharmaceuticals is expected to announce it has hired Paul Herendeen as its new CFO, luring the executive away from Zoetis Inc., according to sources close to the companies.



Some Small Businesses Restore Group Health Coverage

Sun, 21 Aug 2016 13:54:55 EDT

Some small companies that dropped group health insurance are reversing course, driven by a tightening labor market and rising costs and fewer choices for individual coverage.



Nonprofit Hospitals' Business Relationships Can Present Conflicts

Mon, 22 Aug 2016 11:18:40 EDT

Nonprofit hospitals have extensive business ties that can pose conflicts of interests for their administrators and board members, a Wall Street Journal analysis of newly released Internal Revenue Service data shows. While not necessarily improper, administrators and board members sometimes may be forced to choose between what’s best for the hospital and what’s best for their private interests.



Broad Insider-Trading Probe Focuses on Washington Analyst

Fri, 19 Aug 2016 11:13:38 EDT

David Blaszczak, ace predictor of Washington health-policy news, had personal access to federal officials and a knack for tipping off investors to their plans. He’s now facing a federal probe.



U.S. Opens Probe Into Concerns Over Health-Provider Payments

Fri, 19 Aug 2016 10:12:39 EDT

The Obama administration has launched a probe into whether health-care providers such as dialysis centers are steering patients eligible for Medicare and Medicaid benefits into insurance plans offered on the health law’s exchanges.



Valeant Able to Loosen Debt Terms

Fri, 19 Aug 2016 00:33:30 EDT

Valeant Pharmaceuticals International Inc. has again reached a deal with its loan holders to amend its debt terms, giving it more breathing room.



Twins' Plight Shows Human Cost of Syria's Long War

Fri, 19 Aug 2016 03:42:39 EDT

Syrian doctors are using social media to draw attention to the plight of conjoined twins, who are awaiting the documents they need to leave the country for vital surgery.



Study Suggests Zika May Damage Adult Brains

Thu, 18 Aug 2016 17:47:53 EDT

It’s known that Zika can cause brain damage in the fetuses of infected pregnant women. A new study suggests the virus also may be able to harm the brains of some adults.



Zika Cluster in Miami Beach Prompts Investigation From Health Officials

Fri, 19 Aug 2016 13:10:43 EDT

Officials are investigating a cluster of possible Zika cases in Miami Beach, suggesting that transmission of the virus by mosquitoes is more widespread in one of the nation’s more populous counties than originally thought.